Selectively Building Muscle with SAR

Robert J Wills Ph.D., Executive Chairman, GTx, Inc.


Robert Wills, Ph.D.

Robert Wills, Ph.D., currently serves as the Executive Chairman of GTx, Inc, Chairman of the Board of CymaBay Therapeutics, Board member at Parion Sciences, Inc, and a member of the Emerging Companies Section Governing Board of BIO. Prior to these roles, Dr. Wills spent over 25 years at Johnson & Johnson and 10 years at Hoffmann-LaRoche. He holds a BS in Biochemistry, MS in Pharmaceutics from the University of Wisconsin and a PhD in Pharmaceutics from the University of Texas.